The landscape of drug discovery is undergoing a radical transformation, but experts warn that development processes must evolve at the same pace to ensure these innovations reach patients. In a recent New Scientist CoLab podcast, specialists from life sciences leader Cytiva explored the technical challenges inherent in bringing new therapies to the pharmacy shelf.
The Critical Role of Purification
While drug discovery often captures the headlines, the high-stakes science of purification remains a hidden yet essential component of the pipeline. This process is vital for ensuring that complex biological drugs are safe, effective, and free from contaminants. Without advancements in purification technology, the gap between a laboratory breakthrough and a mass-produced drug remains difficult to bridge.
As the industry shifts toward more personalized and complex medicine, Cytiva emphasizes that drug development strategies must be reimagined. The focus is now on creating more efficient, scalable workflows that can handle the intricacies of modern life sciences, ensuring that the next generation of medical treatments can be manufactured reliably at scale.
